202 related articles for article (PubMed ID: 35249786)
1. Risk assessment of malignant transformation of oral leukoplakia in patients with previous oral squamous cell carcinoma.
Yang SW; Lee YC; Lee YS; Chang LC; Lai YR
Int J Oral Maxillofac Surg; 2022 Nov; 51(11):1394-1400. PubMed ID: 35249786
[TBL] [Abstract][Full Text] [Related]
2. Malignant transformation rate of oral leukoplakia in the past 20 years: A systematic review and meta-analysis.
Guan JY; Luo YH; Lin YY; Wu ZY; Ye JY; Xie SM; Li J
J Oral Pathol Med; 2023 Sep; 52(8):691-700. PubMed ID: 37224426
[TBL] [Abstract][Full Text] [Related]
3. The combination of SMAD4 expression and histological grade of dysplasia is a better predictor for the malignant transformation of oral leukoplakia.
Xia RH; Song XM; Wang XJ; Li J; Mao L
PLoS One; 2013; 8(6):e66794. PubMed ID: 23826135
[TBL] [Abstract][Full Text] [Related]
4. Overestimated risk of transformation in oral lichen planus.
Cai X; Zhang J; Zhang H; Li T
Oral Oncol; 2022 Oct; 133():106025. PubMed ID: 35858493
[TBL] [Abstract][Full Text] [Related]
5. Malignant transformation of oral leukoplakia: a retrospective cohort study of 218 Chinese patients.
Liu W; Wang YF; Zhou HW; Shi P; Zhou ZT; Tang GY
BMC Cancer; 2010 Dec; 10():685. PubMed ID: 21159209
[TBL] [Abstract][Full Text] [Related]
6. Elucidating the Genetic Landscape of Oral Leukoplakia to Predict Malignant Transformation.
Wils LJ; Poell JB; Brink A; Evren I; Brouns ER; de Visscher JGAM; Bloemena E; Brakenhoff RH
Clin Cancer Res; 2023 Feb; 29(3):602-613. PubMed ID: 36449687
[TBL] [Abstract][Full Text] [Related]
7. Semiquantifiable angiogenesis parameters in association with the malignant transformation of oral leukoplakia.
Thiem DGE; Schneider S; Venkatraman NT; Kumar VV; Brieger J; Frerich B; Kämmerer PW
J Oral Pathol Med; 2017 Oct; 46(9):710-716. PubMed ID: 28036153
[TBL] [Abstract][Full Text] [Related]
8. Clinicopathologic factors associated with malignant transformation of oral leukoplakias: a retrospective cohort study.
Jäwert F; Pettersson H; Jagefeldt E; Holmberg E; Kjeller G; Öhman J
Int J Oral Maxillofac Surg; 2021 Nov; 50(11):1422-1428. PubMed ID: 33674140
[TBL] [Abstract][Full Text] [Related]
9. Significance of nuclear EGFR and ABCG2 expression in malignant transformation of oral potentially malignant disorders.
Tarle M; Müller D; Raguž M; Lukšić I
Head Neck; 2022 Dec; 44(12):2668-2677. PubMed ID: 36325600
[TBL] [Abstract][Full Text] [Related]
10. Prognostic outcomes of oral squamous cell carcinoma derived from proliferative verrucous leukoplakia: A systematic review.
Faustino ISP; de Pauli Paglioni M; de Almeida Mariz BAL; Normando AGC; Pérez-de-Oliveira ME; Georgaki M; Nikitakis NG; Vargas PA; Santos-Silva AR; Lopes MA
Oral Dis; 2023 May; 29(4):1416-1431. PubMed ID: 35199416
[TBL] [Abstract][Full Text] [Related]
11. Association between hyperglycemia and the malignant transformation of oral leukoplakia in China.
Li J; Liu Y; Zhang H; Hua H
Oral Dis; 2020 Oct; 26(7):1402-1413. PubMed ID: 32348606
[TBL] [Abstract][Full Text] [Related]
12. Copy Number Alterations Predict Development of OSCC from Oral Leukoplakia.
Cai X; Zhang J; Li L; Liu L; Tang M; Zhou X; Peng C; Li X; Chen X; Xu M; Zhang H; Wang J; Huang Y; Li T
J Dent Res; 2024 Feb; 103(2):138-146. PubMed ID: 38217281
[TBL] [Abstract][Full Text] [Related]
13. Wolf in sheep's clothing - Oral proliferative verrucous leukoplakia: Progression with longitudinal molecular insights.
Afkhami M; Maghami E; Gernon TJ; Villaflor V; Bell D
Ann Diagn Pathol; 2023 Apr; 63():152104. PubMed ID: 36640643
[TBL] [Abstract][Full Text] [Related]
14. Transglutaminase 3 contributes to malignant transformation of oral leukoplakia to cancer.
Wu X; Wang R; Jiao J; Li S; Yu J; Yin Z; Zhou L; Gong Z
Int J Biochem Cell Biol; 2018 Nov; 104():34-42. PubMed ID: 30172723
[TBL] [Abstract][Full Text] [Related]
15. EZH2 Expression Correlates With T-Cell Infiltration in Oral Leukoplakia and Predicts Cancer Transformation.
Ganesh D; Dafar A; Niklasson J; Sandberg I; Braz-Silva P; Sapkota D; Öhman J; Giglio D; Hasséus B
Anticancer Res; 2023 Apr; 43(4):1533-1542. PubMed ID: 36974822
[TBL] [Abstract][Full Text] [Related]
16. The role of differentiated dysplasia in the prediction of malignant transformation of oral leukoplakia.
Wils LJ; Poell JB; Peferoen LAN; Evren I; Brouns ER; de Visscher JGAM; van der Meij EH; Brakenhoff RH; Bloemena E
J Oral Pathol Med; 2023 Nov; 52(10):930-938. PubMed ID: 37749621
[TBL] [Abstract][Full Text] [Related]
17. E-cadherin as a potential biomarker of malignant transformation in oral leukoplakia: a retrospective cohort study.
von Zeidler SV; de Souza Botelho T; Mendonça EF; Batista AC
BMC Cancer; 2014 Dec; 14():972. PubMed ID: 25518919
[TBL] [Abstract][Full Text] [Related]
18. Nomogram for risk prediction of malignant transformation in oral leukoplakia patients using combined biomarkers.
Zhang X; Kim KY; Zheng Z; Bazarsad S; Kim J
Oral Oncol; 2017 Sep; 72():132-139. PubMed ID: 28797449
[TBL] [Abstract][Full Text] [Related]
19. Oral tongue leukoplakia: analysis of clinicopathological characteristics, treatment outcomes, and factors related to recurrence and malignant transformation.
Yang SW; Lee YS; Chang LC; Yang CH; Luo CM; Wu PW
Clin Oral Investig; 2021 Jun; 25(6):4045-4058. PubMed ID: 33411001
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical evaluation of galectin-3 expression in oral squamous cell carcinoma, oral leukoplakia and normal mucosa.
Selvaraj FM; Joseph AP; Varun BR; Mony V; Siva Kumar TT
Indian J Dent Res; 2022; 33(3):282-286. PubMed ID: 36656189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
